Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 37 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

37 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
March 3, 2023 AVTR S 10b5-1 3,914 $25.00 $97,850 108,715 Direct -3.48% Disposed -38.6% (price as of 2026-10-02)
Feb. 27, 2023 AVTR S 10b5-1 3,059 $25.00 $76,475 112,629 Direct -2.64% Disposed -38.6% (price as of 2026-10-02)
Feb. 2, 2023 AVTR S 10b5-1 11,339 $25.06 $284,155 102,385 Direct -9.97% Disposed -38.8% (price as of 2026-10-02)
May 20, 2022 AVTR S 10b5-1 19,603 $31.27 $612,986 96,935 Direct -16.82% Disposed -50.9% (price as of 2026-10-02)
March 1, 2022 AVTR S 10b5-1 2,027 $34.47 $69,871 136,221 Direct -1.47% Disposed -55.5% (price as of 2026-10-02)
Feb. 23, 2022 AVTR S 10b5-1 3,059 $33.79 $103,364 125,181 Direct -2.39% Disposed -54.6% (price as of 2026-10-02)
Jan. 5, 2022 AVTR S 10b5-1 11,551 $38.65 $446,446 131,312 Direct -8.09% Disposed -60.3% (price as of 2026-10-02)
Jan. 3, 2022 AVTR S 10b5-1 59,418 $40.77 $2,422,472 142,863 Direct -29.37% Disposed -62.4% (price as of 2026-10-02)
July 30, 2021 AVTR S 10b5-1 81,125 $37.24 $3,021,095 149,379 Direct -35.19% Disposed -58.8% (price as of 2026-10-02)
May 20, 2021 AVTR S 10b5-1 19,603 $31.10 $609,653 149,379 Direct -11.60% Disposed -50.7% (price as of 2026-10-02)
Feb. 24, 2021 AVTR S 10b5-1 3,059 $27.93 $85,438 172,384 Direct -1.74% Disposed -45.1% (price as of 2026-10-02)
Feb. 22, 2021 AVTR S 10b5-1 19,769 $28.62 $565,789 175,443 Direct -10.13% Disposed -46.4% (price as of 2026-10-02)
Jan. 11, 2021 AVTR S 10b5-1 216,332 $30.08 $6,507,267 178,515 Direct -54.79% Disposed -49.0% (price as of 2026-10-02)
Jan. 11, 2021 AVTR S 10b5-1 162,248 $30.04 $4,873,930 178,515 Direct -47.61% Disposed -48.9% (price as of 2026-10-02)
Jan. 6, 2021 AVTR S 10b5-1 11,509 $27.24 $313,505 178,515 Direct -6.06% Disposed -43.7% (price as of 2026-10-02)
Jan. 4, 2021 AVTR S 10b5-1 59,418 $27.84 $1,654,197 190,024 Direct -23.82% Disposed -44.9% (price as of 2026-10-02)
May 20, 2020 AVTR S 10b5-1 25,495 $17.36 $442,593 196,583 Direct -11.48% Disposed -11.6% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 24, 2023 AVTR Stock Options (Right to Buy) Common Stock (49,215) $24.62 Feb. 24, 2033 49,215 Acquired
Feb. 23, 2022 AVTR Stock Options (Right to Buy) Common Stock (43,708) $33.09 Feb. 23, 2032 43,708 Acquired
Jan. 3, 2022 AVTR Stock Options (Right to Buy) Common Stock (59,418) $18.45 Jan. 2, 2030 59,418 Disposed
July 30, 2021 AVTR Stock Options (Right to Buy) Common Stock (81,125) $23.21 July 30, 2028 81,125 Disposed
Feb. 25, 2021 AVTR Stock Options (Right to Buy) Common Stock (52,693) $27.64 Feb. 25, 2031 52,693 Acquired
Feb. 22, 2021 AVTR Stock Options (Right to Buy) Common Stock (19,769) $17.67 Feb. 21, 2030 19,769 Disposed
Jan. 11, 2021 AVTR Stock Options (Right to Buy) Common Stock (162,248) $23.21 July 30, 2028 162,248 Disposed
Jan. 4, 2021 AVTR Stock Options (Right to Buy) Common Stock (59,418) $18.45 Jan. 2, 2030 59,418 Disposed
Feb. 21, 2020 AVTR Stock Options (Right to Buy) Common Stock (79,075) $17.67 Feb. 21, 2030 79,075 Acquired
Jan. 2, 2020 AVTR Stock Options (Right to Buy) Common Stock (178,253) $18.45 Jan. 2, 2030 178,253 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
May 16, 2019 AVTR Stock Options (Right to Buy)→ Common Stock (540,830) 540,830 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

AVTR

President Biopharma Production
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2020 $474,693,184,038 · · $14,333,303,163,639 $519,234,168,185 · $114,005,354 $42,789,963,521,216

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.